PERRITT CAPITAL MANAGEMENT INC - JUNIPER PHARMACEUTICALS INC ownership

JUNIPER PHARMACEUTICALS INC's ticker is JNP and the CUSIP is 48203L107. A total of 48 filers reported holding JUNIPER PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PERRITT CAPITAL MANAGEMENT INC ownership history of JUNIPER PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$1,300,000
+123.8%
149,463
+143.2%
0.38%
+121.8%
Q1 2018$581,000
+274.8%
61,447
+119.8%
0.17%
+335.9%
Q3 2016$155,000
-80.6%
27,950
-75.5%
0.04%
-81.5%
Q2 2016$800,000
+72.8%
114,194
+63.1%
0.21%
+83.5%
Q1 2016$463,000
-38.4%
70,000
-4.1%
0.12%
-29.4%
Q4 2015$752,000
-31.4%
73,000
-21.5%
0.16%
-29.1%
Q3 2015$1,096,000
-23.9%
93,000
-40.9%
0.23%
-10.5%
Q2 2015$1,440,000157,3820.26%
Other shareholders
JUNIPER PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
JW Asset Management, LLC 328,132$3,380,0001.26%
Krensavage Asset Management, LLC 288,326$2,970,0000.95%
EAM Investors, LLC 146,475$1,509,0000.20%
ALGERT GLOBAL LLC 37,017$381,0000.18%
PERRITT CAPITAL MANAGEMENT INC 73,000$752,0000.16%
GSA CAPITAL PARTNERS LLP 174,064$1,793,0000.09%
Bellevue Asset Management AG 50,000$515,0000.08%
Spark Investment Management LLC 45,800$471,0000.06%
CADENCE CAPITAL MANAGEMENT LLC 82,392$849,0000.06%
TFS CAPITAL LLC 34,611$356,0000.04%
View complete list of JUNIPER PHARMACEUTICALS INC shareholders